GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (OTCPK:OPORF) » Definitions » Long-Term Debt

hVIVO (OPORF) Long-Term Debt : $0.00 Mil (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is hVIVO Long-Term Debt?

hVIVO's Long-Term Debt for the quarter that ended in Jun. 2024 was $0.00 Mil.


hVIVO Long-Term Debt Historical Data

The historical data trend for hVIVO's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

hVIVO Long-Term Debt Chart

hVIVO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

hVIVO Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

hVIVO  (OTCPK:OPORF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


hVIVO Long-Term Debt Related Terms

Thank you for viewing the detailed overview of hVIVO's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


hVIVO Business Description

Traded in Other Exchanges
Address
42, New Road, Queen Mary Bioenterprises Innovation Centre, London, GBR, E1 2AX
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

hVIVO Headlines

From GuruFocus

Half Year 2023 hVIVO PLC Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2023 hVIVO PLC Analyst Briefing Transcript

By GuruFocus Research 04-12-2024

Half Year 2024 hVIVO PLC Investor Presentation Transcript

By GuruFocus Research 09-11-2024